Compass Therapeutics, Inc.
Biotechnology company · Boston, Massachusetts, United States · Nasdaq: CMPX
Compass Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker CMPX. It has reported private securities offerings to the US SEC, most recently $110 million sold in a notice filed in 2018.
What does Compass Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $110.2 million sold (2018).
Frequently asked questions about Compass Therapeutics
Where is Compass Therapeutics headquartered?
Compass Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Compass Therapeutics do?
Compass Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Compass Therapeutics a public company?
Yes. Compass Therapeutics, Inc. trades on Nasdaq under the ticker CMPX.
When was Compass Therapeutics founded?
The earliest incorporation on record for Compass Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Elucid Bioimaging Inc.Boston, Massachusetts, United States
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.